William P. Mr. Burke - 10 Nov 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Reporting relationship: Director
Issuer ticker: AXGN
Reported as of: 10 Nov 2025
Net transaction value: -$362,150
SEC form: 4
Accepted by SEC: 13 Nov 2025, 16:31:55 UTC
Prior SEC filing: 07 Nov 2025
Next SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Marc Began, as attorney-in-fact for William Burke

Key filing fact

William P. Mr. Burke filed Form 4 for Axogen, Inc. (AXGN) on 13 Nov 2025.

Key facts

This page summarizes William P. Mr. Burke's Form 4 filing for Axogen, Inc. (AXGN).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 13 Nov 2025, 16:31.

Change

Previous filing in this sequence was filed on 07 Nov 2025.
Current net transaction value: -$362,150.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001682069 Primary reporting owner

Burke William P. Mr.

Relationship: Director
Address: C/O AXOGEN, INC. 13631 PROGRESS BLVD., SUITE 400, ALACHUA
Signature: /s/ Marc Began, as attorney-in-fact for William Burke
Signature date: 13 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXGN transaction

Common Stock

Options Exercise

Transaction value: $156,508
Shares: +19,227
Change %: +19227%
Price: $8.14
Shares after: 19,327
Date: 10 Nov 2025
Ownership: Direct

AXGN transaction

Common Stock

Sale

Transaction value: $461,640
Shares: -19,227
Change %: -99%
Price: $24.01
Shares after: 100
Date: 10 Nov 2025
Ownership: Direct
Footnotes: F1

AXGN transaction

Common Stock

Options Exercise

Transaction value: $29,231
Shares: +3,591
Change %: +3591%
Price: $8.14
Shares after: 3,691
Date: 11 Nov 2025
Ownership: Direct

AXGN transaction

Common Stock

Sale

Transaction value: $86,249
Shares: -3,591
Change %: -97%
Price: $24.02
Shares after: 100
Date: 11 Nov 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXGN transaction Derivative

Stock Option (right to purchase)

Options Exercise

Transaction value: $0
Shares: -19,227
Change %: -84%
Price: $0.000000
Shares after: 3,591
Date: 10 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,227
Exercise price: $8.14
Footnotes: F3

AXGN transaction Derivative

Stock Option (right to purchase)

Options Exercise

Transaction value: $0
Shares: -3,591
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 11 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,591
Exercise price: $8.14
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.10 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F2

The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.13 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.